An assessment of statin safety by hepatologists. Guideline uri icon

Overview

abstract

  • The purpose of the Liver Expert Panel was to provide advice to the National Lipid Association's (NLA) Safety Task Force in response to specific questions concerning liver-associated risks of statin therapy. The panel was composed of academic hepatologists with clinical and research interests in nonalcoholic fatty liver disease, lipid metabolic disorders, and drug hepatotoxicity.

publication date

  • February 3, 2006

Research

keywords

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Liver Failure

Identity

Scopus Document Identifier

  • 33645888317

Digital Object Identifier (DOI)

  • 10.1016/j.amjcard.2005.12.014

PubMed ID

  • 16581333

Additional Document Info

volume

  • 97

issue

  • 8A